Co-amilozide 5mg/50mg tablets

Χώρα: Ηνωμένο Βασίλειο

Γλώσσα: Αγγλικά

Πηγή: MHRA (Medicines & Healthcare Products Regulatory Agency)

Δραστική ουσία:

Amiloride hydrochloride; Hydrochlorothiazide

Διαθέσιμο από:

Wockhardt UK Ltd

Φαρμακολογική κατηγορία (ATC):

C03EA01

INN (Διεθνής Όνομα):

Amiloride hydrochloride; Hydrochlorothiazide

Δοσολογία:

5mg ; 50mg

Φαρμακοτεχνική μορφή:

Oral tablet

Οδός χορήγησης:

Oral

Kατηγορία:

No Controlled Drug Status

Τρόπος διάθεσης:

Valid as a prescribable product

Περίληψη προϊόντος:

BNF: 02020400; GTIN: 5012727902869

Φύλλο οδηγιών χρήσης

MEASURE BAR SHOULD BE 150MM AT 100% SCALE
Customer
Description
Item Code
Profile
Size
Min. Point Size
Market
Language
Proof By
Proof No.
Date
Artwork No.
Pharma
Code
Colours Used
Wockhardt UK Limited
Co-amilozide tablet leaflet common
104104-8
Use uploaded cutter
128 X 390mm
matt.pirie-scott
2
28/10/2015
605346
N/A
Process Black
Keylines
[e-mail]
CLEARLY MARK ANY AMENDMENTS ON ONE PROOF AND RETURN TO MPS
WARNING! We cannot accept responsibility for any errors
in this proof after approval. Whilst we take extreme care
at all times to ensure accuracy to our clientʼs brief,
the final responsibility must be taken by our client.
IF YOU SIGN THIS PROOF YOU ARE SIGNIFYING
FULL APPROVAL OF DESIGN AND TEXT.
UK
English
9pt (main body) / 6.5pt (variables)
PACKAGE LEAFLET: INFORMATION FOR THE USER
CO-AMILOZIDE 2.5MG/25MG & 5MG/50MG TABLETS
Amiloride Hydrochloride and Hydrochlorothiazide
READ ALL OF THIS LEAFLET CAREFULLY BEFORE
YOU START TO TAKE THIS MEDICINE.
- Keep this leaflet. You may need to read
it again.
- If you have any further questions,
please ask your doctor or pharmacist.
- This medicine has been prescribed for
you. Do not pass it on to others. It may
harm them, even if their symptoms are
the same as yours.
- If any of the side effects get serious, or
if you notice any side effects not listed
in this leaflet, please tell your doctor or
pharmacist.
IN THIS LEAFLET:
1. What Co-Amilozide Tablets are and
what they are used for
2. Before you take Co-Amilozide Tablets
3. How to take Co-Amilozide Tablets
4. Possible side effects
5. How to store Co-Amilozide Tablets
6. Further information
1.
WHAT CO-AMILOZIDE TABLETS ARE AND
WHAT THEY ARE USED FOR
The name of your medicine is Co-Amilozide
Tablets. This medicine contains two active
ingredients, amiloride hydrochloride
and hydrochlorothiazide. Amiloride
hydrochloride removes excess water and
prevents a reduction in potassium levels.
Hydrochlorothiazide removes excess
water from the body.
Co-Amilozide Tablets comes in two
strengths and is used in the

Αρχείο Π.Χ.Π.

OBJECT 1
CO-AMILOZIDE 5/50 TABLETS
Summary of Product Characteristics Updated 21-Feb-2017 | Wockhardt UK
Ltd
1. Name of the medicinal product
Co-amilozide 5/50 Tablets
2. Qualitative and quantitative composition
Amiloride Hydrochloride 5mg
Hydrochlorothiazide 50mg
Excipients: lactose.
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Tablet
Cream to very pale buff coloured, odourless, flat bevelled edge
tablets, marked CZ5 on one face and CP
on the reverse.
4. Clinical particulars
4.1 Therapeutic indications
Co-amilozide is indicated in patients with hypertension, congestive
heart failure, or hepatic cirrhosis with
ascites, in whom potassium depletion might be anticipated. Amiloride
hydrochloride in co-amilozide
minimises the possibility of excessive potassium loss during vigorous
diuresis for long term therapy. Co-
amilozide is particularly indicated in conditions where potassium
balance is important, eg patients with
congestive heart failure receiving digitalis.
4.2 Posology and method of administration
The rate of loss of weight and the serum electrolyte levels should
determine the dosage. The most
satisfactory rate of weight loss after initiation of diuresis is about
0.5-1.0 kg/day.
_Hypertension:_ Initially one tablet given once a day. The dosage may
be increased if necessary to two
tablets given once a day or in divided doses.
Co-amilozide may be used alone or as an adjunct to other
antihypertensive drugs, but since the
antihypertensive effect of these agents may be enhanced, their dosage
may need to be reduced in order to
reduce the risk of an excessive drop in pressure.
_Congestive heart failure:_ Initially one tablet a day, subsequently
adjusted if required, but not exceeding
four tablets a day. Optimal dosage is determined by the diuretic
response and the plasma potassium level.
Once initial diuresis has been achieved, reduction in dosage may be
attempted for maintenance therapy.
Maintenance therapy may be on an intermittent basis.
_Hepatic cirrhosis with ascites: _Initiate therapy